Advertisement

Topics

Latest Cancer Disease NewsRSS

14:48 EST 18th November 2017 | BioPortfolio

Bladder cancer Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Bladder cancer Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Bladder cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Bladder cancer prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk fact...

Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 2017 to 2021 [Report Updated: 30102017] Prices from USD $2800

The Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Cancer Angiogenesis Inhibitor industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its dis...

Bile Duct Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Bile Duct Cancer Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Bile Duct Cancer Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.This r...

Colorectal Cancer CRC Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Colorectal Cancer CRC Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Colorectal Cancer CRC in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Colorectal Cancer CRC prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the...

Siddhartha Mukherjee: Gene research critical in fight against cancer

FDA Creates Pathway to Review Tumor Assays Based on Approval of MSK Panel

Memorial Sloan Kettering Cancer Center (MSK) has won the FDA’s first authorization for a first tumor-profiling laboratory-developed test (LDT)—an approval that has led the agency to create a regulatory pathway for reviewing similar assays. MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) is a 468-gene panel intended to detect gene mutations and other critical geneti...

FDA Creates Pathway to Reviewing Tumor Assays Based on Approval of MSK Panel

Memorial Sloan Kettering Cancer Center (MSK) has won FDA authorization for its MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) multiplex oncopanel—the first tumor-profiling laboratory-developed test (LDT) to win agency approval. MSK-IMPACT is a 468-gene panel intended to detect gene mutations and other critical genetic aberrations in both rare and common cancers. Sin...

Opportunities and challenges for biosimilars in oncology

The rapid increase in healthcare costs, particularly for cancer drugs, has had a major impact on providers, practices, payers and patients, according to Dr Gary Lyman of the Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA, USA [1, 2].

Colorectal Cancer CRC Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Colorectal Cancer CRC Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Colorectal Cancer CRC Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152...

FDA expands approval of Sutent to reduce the risk of kidney cancer returning

FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.

Cancer Hope Network recognizes Marietta and Glenn Alba

Earlier this month, Cancer Hope Network honored Marietta and Glenn Alba at the 32nd Annual Chrysalis Gala. The event raised more than $150,000 to provide support for cancer patients and their loved ones. New Jersey (PRWEB) November 16, 2017 “The power of Cancer Hope Network is family – it gives people a place of hope, a place of comfort. I know from personal experience, when you love somebody...

Poliovirus Therapy May Provide a Double Attack on Cancer

An investigational therapy using modified poliovirus to attack cancer appears to unleash the body’s own capacity to fight malignancies by activating a newly identified inflammatory process.

German Cancer Sensor Raises the Alarm and Puts the Fire Out

No need to call the fire brigade! The University of Dresden’s cancer sensor spots a mutation to p53, the most important cancer gene, and kills the cell. Researchers at the University of Dresden, Germany, have developed a molecular sensor that ... This awesome article German Cancer Sensor Raises the Alarm and Puts the Fire Out appeared first on Labiotech.eu. Be kind and don't copy it without ...

Atossa Genetics (ATOS) - Seeking to prevent or treat breast cancer

Edison Investment Research - Pharmaceutical & healthcare - Atossa Genetics: Atossa Genetics reported Phase I data on its topical endoxifen formulation and it is now developing this as a potential treatment for high mammographic breast density (MBD), which is associated with increased breast cancer risk. The firm is also developing oral endoxifen for patients refractory to tamoxifen, and its intrad...

German Diagnostics Firm Tackles Early Detection of Cancer, Alzheimer’s and Parkinson’s

Hummingbird Diagnostics has teamed up with Saarland University to develop molecular diagnostics that can detect serious diseases early using blood samples.  Based in Heidelberg, Germany, Hummingbird Diagnostics develops early diagnostics in multiple disease areas, ranging from cancer to cardiovascular and ... This awesome article German Diagnostics Firm Tackles Early Detection of Cancer, Alzheime...

Anti-Parasite Drug May Help to Treat Prostate Cancer, Say Norwegian Scientists

Researchers in Norway have found that a drug used to kill parasites like tapeworms can slow the growth of prostate and colon cancer cells. A group from the University of Bergen have been testing hundreds of drugs to see how they ... This awesome article Anti-Parasite Drug May Help to Treat Prostate Cancer, Say Norwegian Scientists appeared first on Labiotech.eu. Be kind and don't copy it without ...

Pancreatic cancer is often deadly. But recent discoveries are starting to unravel its mysteries — and raise hope

Pancreatic cancer is difficult to detect and bedeviling to treat, but recent discoveries — both in the lab and in patients — are raising hope.

Aflac Holiday Duck Has a Huge Heart in Fight Against Childhood Cancer

SOURCE: Aflac DESCRIPTION:It’s a warm and fuzzy gift. It’s a keepsake collectable. But, most importantly, it’s a way for anyone and everyone to give from their hearts in the crusade against childhood cancer. That’s right. It’s that time of year for the annual Aflac Holiday Duck to make its debut in Macy’s department stores nationwide and via the company’s own website. All net proc...

Anal CancerEpidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Anal Cancer Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Anal Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Anal Cancer prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, dise...

FDA Nod For Breast Cancer Combo Therapy, RARE Scripts History, EDAP Disappoints

Today's Daily Dose brings you news about FDA approval of Faslodex-Verzenio combo for advanced breast cancer; EDAP's disappointing Q3 results; upcoming clinical trial catalysts of TapImmune, and the first drug to be greenlighted for Sly syndrome.

Pfizer, Novartis agree UK price cuts for new breast cancer drugs

Pfizer and Novartis have agreed price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely within Britain's state-funded health service. FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014.

$5B Biotech Unicorn Moderna Made Its First Cancer Vaccine - For Just One Person

Novel cancer vaccine encodes 20 neoepitopes on a single mRNA molecule to elicit a completely individualized immune response.

With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial

Moderna announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a mRNA-based personalized cancer vaccine.

Tom Marsilje, a relentless advocate for cancer patients, dies at 45

Tom Marsilje was eternally optimistic and willing to give of his time to help his fellow cancer patients find clinical trials and experimental therapies.

Lung Cancer Video Library – Is There An Optimal Chemo Regimen For Squamous Non-Small Cell Lung Cancer (NSCLC)

Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses Is There An Optimal Chemo Regimen For Squamous Non-Small Cell Lung Cancer (NSCLC).Related Posts:

Quick Search
Advertisement
 

review and buy Cancer Disease market research data and corporate reports here